Synchron acquires equity stake in ACQUANDAS

Synchron announced the acquisition of an equity stake in ACQUANDAS.

As part of the transaction, Tom Oxley, Synchron’s CEO & Founder, will join the ACQUANDAS Governance Council and Riki Banerjee, Synchron’s CTO, will join as Observer.

“As we pioneer functional endovascular neurotechnology, this investment strengthens our technology innovation and supply chain for our unique product offerings, beginning with brain-computer interfaces,” said Oxley.

“After many years of development in fabrication technology, I am thrilled to welcome Synchron on board as an investor. This major investment will not only strengthen our existing partnership but will also play a pivotal role in expanding our facilities and capabilities. It serves as a testament to the readiness of our fabrication technology and our company for the market,” said CEO & Founder Dr Rodrigo Lima de Miranda, ACQUANDAS.

ACQUANDAS has established an entirely new generation of shape-memory, flexible metallic components suitable for use as medical devices.
MB Bureau